Tadao Kakizoe
Directeur/Bestuurslid bij NIPPON TELEVISION HOLDINGS, INC.
Profiel
Tadao Kakizoe is currently the Chairman at Japan Cancer Society since 2012, Chairman at Association For Nuclear Technology In Medicine since 2014, Independent Outside Director at Nippon Television Holdings, Inc. since 2011, Non-Executive Director at Nippon Television Network Corp., and Independent Outside Director at Kanamic Network Co., LTD.
since 2014.
He was also a former Independent Director at Terumo Corp.
from 2009 to 2012.
Actieve functies van Tadao Kakizoe
Bedrijven | Functie | Begin |
---|---|---|
NIPPON TELEVISION HOLDINGS, INC. | Directeur/Bestuurslid | 03-08-2011 |
KANAMIC NETWORK CO.,LTD | Directeur/Bestuurslid | 01-02-2014 |
Japan Cancer Society | Voorzitter | 07-02-2012 |
Nippon Television Network Corp.
Nippon Television Network Corp. BroadcastingConsumer Services Nippon Television Network Corp. engages in general broadcasting business and media business. The company was founded on October 15, 1952 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | - |
Association For Nuclear Technology In Medicine | Voorzitter | 01-06-2014 |
Eerdere bekende functies van Tadao Kakizoe
Bedrijven | Functie | Einde |
---|---|---|
TERUMO CORPORATION | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
TERUMO CORPORATION | Health Technology |
NIPPON TELEVISION HOLDINGS, INC. | Consumer Services |
KANAMIC NETWORK CO.,LTD | Technology Services |
Bedrijven in privébezit | 3 |
---|---|
Japan Cancer Society | |
Nippon Television Network Corp.
Nippon Television Network Corp. BroadcastingConsumer Services Nippon Television Network Corp. engages in general broadcasting business and media business. The company was founded on October 15, 1952 and is headquartered in Tokyo, Japan. | Consumer Services |
Association For Nuclear Technology In Medicine |